COVID-19 and the challenge of herd immunity: what role can the law play, asks Sarah Moore
Now more than ever before, it is crucial that UK litigators find new ways to hold Big Pharma to account, argues Sarah Moore
Sarah Moore reviews the current state of product liability in the UK, & asks: is it time for a consumer revolution?
Political & product liability: Sarah Moore highlights what politicians & toothpaste do not have in common
Are “Big Pharma” & voluntary codes ending the Dark Age of industry bias, asks Sarah Moore
Will the issues of e-cigarettes & plain packaging re-ignite tobacco litigation, asks Sarah Moore
What impact will the new European Medical Device Regulations have on UK medicine, asks Sarah Moore
Sarah Moore exposes some regulatory deficiencies in the world of vitamins & supplements
MOVERS & SHAKERS
Gilson Gray—Linda Pope
Partner joins family law team inLondon
Jackson Lees Group—five promotions
Private client division announces five new partners
Taylor Wessing—Max Millington
Banking and finance team welcomes partner in London
NEWS
The landmark Supreme Court’s decision in Johnson v FirstRand Bank Ltd—along with Rukhadze v Recovery Partners—redefine fiduciary duties in commercial fraud. Writing in NLJ this week, Mary Young of Kingsley Napley analyses the implications of the rulings
Barristers Ben Keith of 5 St Andrew’s Hill and Rhys Davies of Temple Garden Chambers use the arrest of Simon Leviev—the so-called Tinder Swindler—to explore the realities of Interpol red notices, in this week's NLJ
Mazur v Charles Russell Speechlys [2025] has upended assumptions about who may conduct litigation, warn Kevin Latham and Fraser Barnstaple of Kings Chambers in this week's NLJ. But is it as catastrophic as first feared?
Lord Sales has been appointed to become the Deputy President of the Supreme Court after Lord Hodge retires at the end of the year
Limited liability partnerships (LLPs) are reportedly in the firing line in Chancellor Rachel Reeves upcoming Autumn budget
Copyright © 2025 LexisNexis
